selectiveAccumulationOfOsteopontinAndInVivo
limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
historyOfBreast-conservingSurgery
cohortOfPatientsWithAdenomasInOutpatientClinic
diagnosticSensitivityForWomenWithDenseBreasts
intravenousAdministration
greater
representativeSignatures
20%IncreasedRisk
variableMechanismsOfCarcinogenesis
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
accomplished
meta-analysis
henceCurrentlyImplementedInScreeningAtRiskOfBreastCancer
stillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
familyImpact
betterOutcomeWithGoodValue
henceCurrentlyOnlyRoutinelyImplemented
complexDisease
definitiveDiagnosis
patientWithHer2
stillNecessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
amount
rareEntityWithOnlyCasesHavingReported
secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
overviewOfBreastMriProtocols
20%RiskOfBreastCancerAmongCurrentContraceptionUsers
potentialOfAionAsMultimodalContrastAgentForBreastCancerDiagnosis
thanFamiliesOfPatients
increasedRiskWithUseOfLevonorgestrelSystem-bothOfImportantFindings
years2005-2017
inTumorImaging
commonAgentsUsedInBreastCancerTreatment
assessment
recognized
triple-negativeBreastCancers
increasedRiskAmongContraceptionUsers
entityWithOnlyCases
0.004
entityWithFewCasesHavingReported
accumulationOfFluorescentOsteopontinInVitroAnd
tnbcCells
ageThanPatients
breastCancerDetection
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesMainlyWithTrastuzumab
patientsInStudy
diagnosticPerformanceOfPetImagingInPatients
them
theirAbility
accumulationInVitroAndInVivo
differentialDiagnosis
currentlyRoutinelyImplementedInScreeningAtIncreasedRisk
novelClinicalStrategies
associationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
veryRareClinicalEntityWithFewCasesHavingReportedToDate
associationAmongWomenWithBreastCancer
detectionOfBreastCancerInWomen
invasiveBreastCancer
largeCohort
found
familialCancerClusteringInPatients
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithTrastuzumab
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisMainlyWithTrastuzumab
multipleFactors
mechanismsOfCarcinogenesis
henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
significantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
20%RiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
inConclusionStillNecessaryForAdoption
combinationsOfInductionInBrca1Wild-typeBreastCancer
theirAbilityOfPrognosisPrediction
accumulatedDoseOfTreatment
currentlyImplementedInScreeningOfWomenAtRiskOfBreastCancer
parpTreatments
henceOnlyRoutinelyImplemented
underutilized
confidenceIntervals
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsWithTrastuzumab
mustAddressed
higherRiskForMalignancy
henceImplementedInScreeningAtRisk
stillNecessaryForAdoptionAsClinicalBiomarkerInPatients
20%IncreasedRiskOfBreastCancer
onlyRoutinelyImplementedInScreeningAtIncreasedRisk
alsoShaped
treatment
maySmall
formedByCo-encapsulationOfFluorophoreInMicelles
evidenceForAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
evidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
petProbe68ga-pentixafor
potentialAsContrastAgentForBreastCancerDiagnosis
veryRareEntityWithOnlyFewCases
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterTissueSampling
toolForTargetedTreatmentOfCancerIncludingBc
currentlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
confirmationUsingNearInfraredImaging
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
18f-fdgPet
henceImplementedInScreeningAtIncreasedRiskOfBreastCancer
breastCancers
variableMolecularMechanisms
at25HPost-injectionGreaterInTumorBedRespectively
clinicalBiomarkerInPatients
breastTumor
largelyConsistent
necessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
54%
riskWithUse
largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAlone
CBC
henceOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesWithTrastuzumab
strongContrastWithImagingModalities
preciseToolForTreatmentIncludingBc
effectiveDiagnosisOfBreastCancer
brca1Wild-typeTnbcCells
results
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationWithTrastuzumab
selectedCasesWithNeuromas
haveValidatedByStudiesMainlyWithTrastuzumab
increasedRiskWithUseOfLevonorgestrelSystem-bothOfFindings
betterOutcome
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombination
veryComplexDisease
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesWithTrastuzumab
additionalIndicator
implementedInScreeningOfWomenAtIncreasedRisk
previousDecades
riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfFindings
biomarkerInPatientsWithBreastCancer
stillNecessaryForAdoptionAsRoutineBiomarker
necessaryForAdoptionOfCtnAsBiomarker
haveValidatedMainlyWithTrastuzumab
confirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
performance
inConclusionNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
heterogeneousCancerInFemalePatients
abbreviatedMriProtocols
inConclusionNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
second
inConclusionNecessaryForAdoptionAsRoutineBiomarker
evidencedByIncrease
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
molecularMechanisms
rareEntityWithCases
outcome
SUVmax
subcutaneousBreastTumorInNudeMice
henceCurrentlyImplementedInScreeningAtRisk
outcomeOverCosts
selectiveAccumulationOfOsteopontin
recorded
veryRareCase
inConclusionStillNecessaryAsClinicalBiomarker
cxcr4ExpressionDeterminedByImmunohistochemistry
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfImportantFindings
20%RiskOfBreastCancer
henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
herEjectionFraction
henceImplementedInScreeningAtRiskOfBreastCancer
specificCancerCell-relatedComponents
anti-her2Treatment
continuing
entityWithCases
performanceOfPetImaging
reportedInProportionOfPatientsWithPa
combinations
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedMainlyWithTrastuzumab
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
infraredImagingInTripleNegativeInVitro
veryRareEntityWithOnlyCasesHavingReported
significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
riskOfBreastCancerAmongHormonalContraceptionUsers
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
randomEffectsModel
performanceOfCxcr4-directedPetImagingInPatients
increasedRiskAmongHormonalContraceptionUsers
20%IncreasedRiskAmongCurrentHormonalContraceptionUsers
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
earlyDiagnosisOfCardiotoxicity
veryRareEntityWithOnlyFewCasesHavingReported
postmenopausalPatient
brd4Regulation
biomarker
inConclusionStillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
secondaryConfirmationOfSignalAccumulationUsingNearInfraredImaging
routineBiomarkerInPatientsWithBreastCancer
useOfAdvancedImagingExaminations
introducedCxcr4-targetedPetProbe68ga-pentixafor
potentialAsEffectiveContrastAgent
inConclusionNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
inConclusionStillNecessaryAsClinicalBiomarkerInPatientsWithBreastCancer
prolactinomas
typeOfSurgery
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
inConclusionNecessaryForAdoptionOfCtnAsRoutineBiomarker
furthermoreDiagnosedWithPaAtEarlierAge
presentingWithNeuropathicBreastPain
haveValidatedByStudiesWithTrastuzumab
henceCurrentlyImplementedInScreeningAtIncreasedRiskOfBreastCancer
currentlyImplementedInScreeningOfWomenAtRisk
effectiveDiagnosis
routineClinicalBiomarkerInPatients
25Months
toolForTreatmentOfCancerIncludingBc
rareEntityWithCasesHavingReported
evidenceForInverseAssociationAmongWomenWithBreastCancer
at25HPost-injectionGreaterThanInKidney
stillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
diagnosedWithPaAtEarlierAgeThanPatients
tripleNegativeInVitro
furthermoreDiagnosedWithPaAtAgeThanPatientsWithNegativeFamilyHistory
useOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
diagnosisOfSyndromes
included
onlyFewCasesHavingReportedToDate
thanFamiliesOfPatientsWithAdenomas
screening
feasibleInCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
humanErrors
henceOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
limitedEvidenceForAssociationAmongWomenWithBreastCancer
mostSensitiveTestForBreastCancerDetection
significantPrognosticValue
obtained
measured
combinationsOfInductionInBrca1TripleNegativeBreastCancer
selectiveAccumulationAnd
thereforeHasAppliedToIdentification
largeCohortOfPatientsWithPituitaryAdenomas
entityWithFewCases
chestWallLesions
tool
accumulationOfOsteopontinInVitroAnd
givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
rareEntityWithFewCases
veryRareEntityWithFewCases
mostCommonCancer
accumulationOfOsteopontinAndInVivo
evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
necessaryForAdoptionAsClinicalBiomarkerInPatients
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombination
feasibleInSelectedCasesAfterAccurateTissueSampling
fiveDosesOfAdjuvantTranstuzumab
veryRareEntityWithOnlyCases
inConclusionStillNecessaryAsBiomarkerInPatients
20%Risk
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
ageThanPatientsWithFamilyHistory
outcomesOfEstrogenPositive
limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-carotene
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationMainlyWithTrastuzumab
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesMainlyWithTrastuzumab
inConclusionStillNecessaryAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
formulationOfEffectiveManagementPlan
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
furthermoreDiagnosedWithPaAtAge
lungCancer
differentContrastAgent
lapatinib
widerPopulationOfTnbcPatients
increasedRiskOfBreastCancerAmongHormonalContraceptionUsers
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
images
stillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
otherGenes
selectiveAccumulationOfFluorescentOsteopontinInVitroAnd
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
developedCbcAmong
adoption
diagnosticPerformanceOfCxcr4-directedPetImaging
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
inConclusionNecessaryForAdoptionOfCtnAsBiomarker
potentialOfAionAsContrastAgentForBreastCancerDiagnosis
woundDrains
theirBeliefs
riskWithUseOfLevonorgestrelSystem-bothOfFindings
betterOutcomeWithPredictiveValue
mechanisms
discovery
due
diagnosisInPatientsWithHistory
stillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
managementOfTumour-relatedSymptoms
presentingWithBreastPain
clinicalEntityWithOnlyFewCasesHavingReportedToDate
BRD4
refractoryNeuropathicBreastPain
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
inConclusionNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
selectiveAccumulationInVitroAndInVivo
necessaryForAdoptionAsRoutineBiomarker
henceRoutinelyImplemented
diagnosisInPatients
newlyIdentified
outcomeWithNegativeValue
limitedEvidenceForSignificantlyInverseAssociationAmongWomenWithBreastCancer
subtype-specificPrognosticSignatures
inConclusionNecessaryForAdoptionOfCtn
specificCancerComponents
flowCytometry
benefits
onlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineBiomarker
preciseToolForTreatment
combinationsOfInductionInBrca1NegativeBreastCancer
veryRareEntityWithCasesHavingReported
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsMainlyWithTrastuzumab
associationBetweenPost-diagnosisUse
modifiedFactor
19
themselves
infraredFluorescentImagingInNegativeInVitro
inConclusionStillNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
henceRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
region
dnaDamageRegulation
presenceOfMetastaticDiseaseAtPresentation
haveValidated
complex
inverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
entityWithOnlyCasesHavingReported
clinicalEntityWithFewCasesHavingReportedToDate
goodNegativePredictiveValue
23Studies
hasMainlyAssociatedWithMutations
visuallyDetectable
previousStudies
useOfImagingExaminations
confirmationUsingNearInfraredFluorescentImaging
56%
recentlyHaveDeveloped
inConclusionStillNecessaryForAdoptionAsClinicalBiomarkerInPatients
subtype-specificSignatures
myocardialInjury
necessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
lowDiagnosticSensitivityForWomenWithDenseBreasts
reportedInProportion
theirBeliefsRegardingCancerCausation
hasAssociatedWithMutationsInBrca1
inConclusionStillNecessaryAsRoutineBiomarkerInPatients
areInvestigatedForBreastCancerDiagnosis
test
molecularMechanismsOfCarcinogenesis
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneWithTrastuzumab
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
diet
entityWithOnlyFewCasesHavingReported
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfFindings
givenConcernsAreInvestigatedForBreastCancerDiagnosis
glycosylationOfMembraneTypeMr
therapeuticBenefits
ourPreliminaryMolecularBiologyExperimentData
increasedRiskWithUse
cancerInPatientsWorldwide
earlierAgeThanPatients
currentlyImplemented
implemented
preciseToolForTargetedTreatmentIncludingBc
associationBetweenIntakeOfB-carotene
greaterInTumorBedThanInKidneyRespectively
cohortOfPatientsWithAdenomas
performanceInPatientsWithBreastCancer
additionalAnti-her2Therapy
outcomesOfEstrogenReceptorPositive
inConclusionNecessaryAsBiomarkerInPatients
heterogeneousCancerInPatients
NAC
brcanessPhenotypeInBrca1Wild-typeTnbcCells
protected
widerPopulation
henceCurrentlyImplementedInScreeningAtIncreasedRisk
cardiotoxicityDiagnosis
updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
strongFactor
mammography
feasibleInSelectedCasesWithNeuromasAfterTissueSampling
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
haveValidatedWithTrastuzumab
outcomeWithGoodNegativePredictiveValue
life
cohortOfPatients
accumulationOfOsteopontin
implementedInScreeningOfWomenAtRiskOfBreastCancer
hasMainlyAssociatedWithMutationsInBrca1
comparedSemi-quantitatively
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
increase
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationWithTrastuzumab
brca1Wild-typeTripleNegativeBreastCancer
theirExperiencesLiving
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
IORT
betterOutcomeWithGoodNegativePredictiveValue
harmfulorTissues
diagnosticPerformanceInPatients
hasAssociated
diagnosticSensitivity
hazardRatios
elderlyPatient
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
825Ml
henceOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
systemicTherapy
mostInvasiveDisease
notablyDesigned
haveDeveloped
associationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
sensitive
performed
recurrentDisease
mostCommonAgents
majorConcerns
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
onlyRoutinelyImplementedInScreeningAtRisk
misdiagnosis
significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
currentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
routineBiomarker
mayIndicativeOfLesion
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
patientsWithLabc
historicallyInvolved
fiveDoses
bindingToBreastCancerCells
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDoses
sensitiveTest
type
meanSuvmaxOf35
rareClinicalEntityWithCasesHavingReportedToDate
stillNecessaryForAdoptionAsBiomarker
strongFamilyHistoryOfCancer
strongIndependentPrognosticFactor
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisWithTrastuzumab
rareEntityWithFewCasesHavingReported
increasedRiskOfBreastCancerAmongContraceptionUsers
inConclusionNecessaryForAdoptionAsBiomarker
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclines
diagnosedWithPaAtAgeThanPatientsWithFamilyHistory
accurateTissueSampling
variableMolecularMechanismsOfCarcinogenesis
clinicalEntityWithOnlyCasesHavingReportedToDate
inConclusionStillNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
selectiveAccumulationOfOsteopontinInVitroAnd
rareClinicalEntityWithOnlyCasesHavingReportedToDate
inConclusionNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationWithTrastuzumab
brca1Levels
necessaryForAdoptionOfCtnAsRoutineBiomarker
henceCurrentlyRoutinelyImplemented
inConclusionStillNecessaryForAdoptionOfCtnAsBiomarker
inConclusionNecessaryAsClinicalBiomarker
toolForTreatmentOfCancer
enhancementOfImage
howeverUnderutilized
secondaryConfirmationUsingNearInfraredFluorescentImaging
sensitivityForWomen
rareClinicalEntity
henceRoutinelyImplementedInScreeningOfWomenAtRisk
oneYearWithoutDeterioration
riskAmongContraceptionUsers
significantlyInverseAssociationAmongWomenWithBreastCancer
currentlyOnlyRoutinelyImplementedInScreeningAtRisk
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
issuesOfExistingContrastAgents
evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
associationBetweenPost-diagnosisLow-doseAspirinUse
status
givenConcernsAboutContrastAgentsAreInvestigated
recentlyIntroducedCxcr4-targetedPetProbe68ga-pentixafor
advancedImaging
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclines
lowSensitivityForWomenWithBreasts
henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
20%RiskAmongCurrentContraceptionUsers
feasibleInSelectedCasesWithNeuromasAfterAccurateTissueSampling
veryRareClinicalEntityWithCasesHavingReportedToDate
diagnosisOfAcuteSyndromes
enhancement
patientWithRelapsedHer2
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
20%IncreasedRiskOfBreastCancerAmongCurrentContraceptionUsers
evidenceForSignificantlyInverseAssociationAmongWomenWithBreastCancer
total
associationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
inConclusionNecessaryAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
estimated
henceRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
currentlyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
responsible
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreated
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
inConclusionStillNecessaryAsRoutineClinicalBiomarker
inverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
presenceOfDisease
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
tissueSampling
thesuspiciousRegion
fluorescentImaging
intravenousAdministrationOfOsteopontin-750Probe
veryRareEntityWithCases
inConclusionNecessaryForAdoption
necessaryForAdoptionAsBiomarker
rareEntityWithOnlyFewCases
LABC
detectionInWomen
cancerCell-relatedComponents
amongThemNewlyIdentifiedInStudy
currentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
differentBiomarkers
properlySelectedCasesWithAsymptomaticNeuromas
betInhibitorsAvailableInClinic
inConclusionStillNecessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
inConclusionNecessaryAsRoutineClinicalBiomarker
cancerClusteringInPatientsWithProlactinoma
henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
nudeMice
onlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
medianFollow-upOf48Years
entityWithCasesHavingReported
sensitivityForWomenWithBreasts
associationBetweenAspirinUse
mustAddressedDuringCancerCounselingConsultations
formulation
commonAgentsUsed
feasibleInSelectedCasesAfterTissueSampling
stillNecessaryForAdoptionOfCtnAsRoutineBiomarker
patients
rareClinicalEntityWithOnlyFewCasesHavingReportedToDate
inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
developed
familyHistory
formulationOfManagementPlanForWomen
feasibleInCasesWithAsymptomaticNeuromasAfterTissueSampling
infraredImagingInNegativeInVitro
imagingInTripleNegative
necessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
necessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
diagnosticPerformanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer
lungCancerInHuman
at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
rareEntityWithOnlyCases
ourPreliminaryBiologyExperimentData
currentlyRoutinelyImplementedInScreeningAtRisk
malign
areAlsoInvestigated
therapeuticApproachesEspeciallyUnderViewOfCurrentDevelopments
riskAmongHormonalContraceptionUsers
analysis
inConclusionStillNecessaryForAdoptionAsRoutineBiomarker
routinelyImplementedInScreeningAtRiskOfBreastCancer
20%RiskAmongCurrentHormonalContraceptionUsers
updateOnRiskFactorsForSeromaProduction
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneWithTrastuzumab
performanceOfPetImagingInPatientsWithBreastCancer
cancer
clinicalStrategies
outcomeWithGoodValue
casesWithAsymptomaticNeuromas
associationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
potentialOfAionAsEffectiveMultimodalContrastAgent
veryRareClinicalEntityWithOnlyCasesHavingReportedToDate
stillNecessaryForAdoptionOfCtnAsBiomarker
potential
accumulationAnd
limitedEvidenceForInverseAssociationAmongWomenWithBreastCancer
outcomeWithPredictiveValue
agents
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationWithTrastuzumab
analyzed
commonlyDiagnosed
strongIndependentFactor
henceRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
inverseAssociationBetweenPrediagnosisIntakeOfB-carotene
secondaryConfirmationUsingNearInfraredImaging
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDoses
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
ourMolecularBiologyExperimentData
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesMainlyWithTrastuzumab
inConclusionStillNecessaryForAdoptionAsBiomarker
veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
entityWithOnlyFewCases
familyMemberAffectedWithCancer
evidenceForAssociationAmongWomenWithBreastCancer
women
evidencedByIncreaseInContrastAfterInjection
potentialOfAionAsEffectiveContrastAgent
earlierAgeThanPatientsWithFamilyHistory
dualApproach
reportedInSignificantlyHigherProportionOfPatients
severalRepresentativeGene-expression-basedSignatures
disease
representativeGene-expression-basedSignatures
hasAppliedToIdentification
evaluatedInVivo
amountOfVariation
adoptionOfCtn
givenConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigated
inConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
consistent
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombination
rareEntityWithOnlyFewCasesHavingReported
inConclusionNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombination
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosis
conventionalImaging
evidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
lowSensitivityForWomen
bindingInVitro
fluorescentImagingInNegative
implementedInScreeningOfWomenAtRisk
differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
case
variableMechanisms
60Years
oneYearOfDiseaseControlWithoutDeterioration
riskOfBreastCancerAmongContraceptionUsers
121%OfPatientsWithProlactinomas
inverseAssociationAmongWomenWithBreastCancer
mayUsed
metastaticDiseaseOnPresentation
combinationsOfInduction
fluorescentDye
necessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
thanFamiliesOfPatientsWithNon-functioningAdenomas
femaleSibling
severalRepresentativeSignatures
cancerInFemalePatientsWorldwide
presenceAtPresentation
evidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
20%IncreasedRiskAmongCurrentContraceptionUsers
accumulationOfFluorescentOsteopontin
strongPrognosticFactor
givenConcernsAboutContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
formedByCo-encapsulationOfNear-infraredFluorophoreInMicelles
ourExperience
physicalFinding
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
selectiveAccumulationOfFluorescentOsteopontin
infraredFluorescentImagingInTripleNegativeInVitro
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationMainlyWithTrastuzumab
homologousRecombination-mediatedDnaRepair
inConclusionNecessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
administration
reserved
evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
dose-dependentReduction
cancerComponents
treatmentOptions
lowDiagnosticSensitivity
givenRecentConcernsAboutContrastAgentsAreAlsoInvestigated
thusWouldCrucial
inConclusionNecessaryAsClinicalBiomarkerInPatientsWithBreastCancer
theirOriginallyTargetedPopulationsOfBreastCancer
wouldCrucial
apoptosis
reductionInBrca1Levels
breastCancerDiagnosis
veryRareClinicalEntity
potentialAsEffectiveMultimodalContrastAgent
independent
veryRareEntityWithFewCasesHavingReported
375%
necessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
imaging
issues
inConclusionNecessaryForAdoptionAsClinicalBiomarkerInPatients
subcutaneousBreastTumorInMice
limitedEvidenceForAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
rareCase
rareClinicalEntityWithFewCasesHavingReportedToDate
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAlone
previousBreast/axillarySurgery
20%IncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
betInhibitorsAlreadyAvailableInClinic
haveValidatedByStudies
stillNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
diagnosisProcess
betInhibitors
neuralNetworkClassifier
asResultAreUsed
dnaDamage
betterOutcomeWithNegativeValue
necessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
cellCycleRegulators
imagingInNegative
medicalConsultation
givenRecentConcernsAboutContrastAgentsAreInvestigatedForBreastCancerDiagnosis
currentlyImplementedInScreeningOfWomenAtIncreasedRisk
combinationsOfInductionInBrca1Wild-typeTripleBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesWithTrastuzumab
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesMainlyWithTrastuzumab
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
allFiveCases
safetyIssues
mutationalStatus
formulationOfEffectiveManagementPlanForAt-riskWomen
inverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
follow-upOf48Years
routinelyImplementedInScreeningAtIncreasedRisk
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombination
cancerClustering
refractoryBreastPain
associationBetweenPrediagnosisDietaryIntakeOfB-carotene
tumorBed
diagnosisOfResponseToTreatment
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
diagnosed
inConclusionNecessaryAsRoutineBiomarkerInPatients
accumulationOfFluorescentOsteopontinAndInVivo
involvedInDnaDamageRegulation
givenConcernsAreAlsoInvestigated
associationBetweenPost-diagnosisAspirinUse
givenRecentConcernsAboutGadolinium-basedContrastAgentsAreInvestigated
henceOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
currentlyOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
selectedCases
associationBetweenPrediagnosisIntakeOfB-carotene
established
contrastAgents
cohortOfPatientsInOutpatientClinic
diagnosedWithPaAtEarlierAgeThanPatientsWithFamilyHistory
effectiveTechniqueused
associationBetweenUse
hasMainlyAssociated
formedByCo-encapsulationInMicelles
potentialOfAion
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatients
typeOfPa
additionalTherapy
3.5
confirmationOfSignalAccumulationUsingNearInfraredImaging
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombination
higherRisk
riskWithUseOfLevonorgestrelSystem-bothOfImportantFindings
routinelyImplementedInScreeningAtRisk
evidenceForAssociationBetweenPrediagnosisIntakeOfB-carotene
significantValue
correspondingCohort
fluorescent
hasFound
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
121%OfPatients
henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
hasAssociatedWithMutations
prognostic
givenConcernsAboutGadolinium-basedContrastAgentsAreInvestigatedForBreastCancerDiagnosis
clinicalEntityWithCasesHavingReportedToDate
managementOfSymptoms
toolForTargetedTreatmentOfCancer
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
henceImplementedInScreeningAtIncreasedRisk
micelles
reportedInHigherProportionOfPatients
preciseToolForTargetedTreatment
familyMemberAffected
implementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
inConclusionStillNecessaryForAdoptionOfCtn
furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
potentialAsMultimodalContrastAgentForBreastCancerDiagnosis
amountOfObservedVariation
currentlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
theirExperiencesLivingWithSister
stillNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
familyMember
givenRecentConcernsAreAlsoInvestigatedForBreastCancerDiagnosis
clinicalEntity
diagnosedWithPaAtAgeThanPatients
fluorescentImagingInTripleNegative
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesWithTrastuzumab
administrationOfOsteopontin-750Probe
routinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
increaseInContrastAfterInjection
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
summaryHazardRatioOf070ForHighestIntake
radiotherapy
recentlyFound
understand
rare
riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfImportantFindings
selectiveAccumulationOfFluorescentOsteopontinAndInVivo
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
associationBetweenLow-doseAspirinUse
anthracyclines
highlyExpressed
approach
givenRecentConcernsAreInvestigated
seromaProduction
directional
henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtRisk
ourBiologyExperimentData
mayTooSmall
earlyDiagnosis
networkClassifier
preciseTool
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-both
wouldCrucialForApplicationOfPreventiveStrategies
fluorescentImagingInNegativeInVitro
HRs
stillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
highSensitivity
invasiveDisease
largeCohortOfPatientsInOutpatientClinic
limitedEvidence
performedFromInceptionToJanuary312018
discussed
patientsWithBreastCancerReceiving
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
patient'sOutcomeOverCosts
independentPrognosticFactor
evidence
necessaryForAdoptionOfCtnAsClinicalBiomarker
diagnosedWithPaAtAgeThanPatientsWithNegativeFamilyHistory
increasedRiskWithUseOfLevonorgestrelSystem-both
differentialDiagnosisInPatientsWithHistory
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
elderlyPatientWithRelapsedHer2
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationWithTrastuzumab
inConclusionNecessaryForAdoptionOfCtnAsClinicalBiomarker
itsUse
reportedInHigherProportionOfPatientsWithPa
haveValidatedByStudiesInCardiotoxicityDiagnosis
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntake
stillNecessaryForAdoptionOfCtnAsBiomarkerInPatients
inConclusionStillNecessaryAsRoutineBiomarkerInPatientsWithBreastCancer
harmfulorHarmlessTissues
contrastAgent
veryRareClinicalEntityWithCases
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneWithTrastuzumab
breastTumorInMice
familyMembers
rareEntityWithFewCasesHavingReportedToDate
combination
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesWithTrastuzumab
veryRareClinicalEntityWithOnlyCasesHavingReported
henceCurrentlyOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
MSOT
feasibleInSelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
potentialAsMultimodalContrastAgent
mostSensitiveTest
prognosticValue
henceCurrentlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
cancerInFemalePatients
one-yearExposureLag
formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
necessary
co-encapsulationOfNear-infraredFluorophore
imagingInTripleNegativeInVitro
advancedDiagnosticImaging
thanFamilies
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreated
feasibleInProperlySelectedCasesAfterTissueSampling
onlyFewCases
veryRareClinicalEntityWithFewCases
techniqueused
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsWithTrastuzumab
evidenceForAssociationBetweenPrediagnosisIntakeAmongWomen
gene-expression-basedSignatures
confirmationUsingNearImaging
feasibleInSelectedCasesWithAsymptomaticNeuromasAfterTissueSampling
associationBetweenPrediagnosisIntakeAmongWomen
medianFollow-up
inverseAssociationBetweenPrediagnosisDietaryIntake
haveValidatedByStudiesInCardiotoxicityDiagnosisMainlyWithTrastuzumab
differentiallyExpressed
neuropathicBreastPain
properlySelectedCasesWithNeuromas
oneYearWithoutDeteriorationInHerEjectionFraction
farHasAssociatedWithMutations
stillNecessaryForAdoptionAsClinicalBiomarker
associationBetweenPrediagnosisDietaryIntakeAmongWomen
thereforeHasApplied
currentUsersOfLongerDuration
evidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
inConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
reportedInSignificantlyHigherProportionOfPatientsWithPa
moreCommonlyDiagnosed
associationBetweenUseOfLow-doseAspirin
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulations
management
whenPresent
feasibleInCasesAfterTissueSampling
outcomeWithGoodPredictiveValue
mostCommonAgentsUsed
henceImplementedInScreeningOfWomenAtRisk
diagnosticPerformanceOfCxcr4-directedPetImagingInPatients
biomarkerInPatients
parpInhibitors-basedTreatments
combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer
studies
phantomImaging
presenceOfMetastaticDisease
confirmationOfSignalAccumulationUsingNearFluorescentImaging
rareClinicalEntityWithCasesHavingReported
givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigated
limitations
diagnosedWithPaAtAge
outcomes
inception
theirAbilityOfPrognosisPredictionInTheirTargetedPopulationsOfBreastCancer
denseBreasts
necessaryForAdoptionAsBiomarkerInPatients
reportedInSignificantlyHigherProportion
fluorescentImagingInTripleNegativeInVitro
cxcr4-targetedPetProbe68ga-pentixafor
needed
associationBetweenUseOfAspirin
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
onlyRoutinelyImplementedInScreeningOfWomenAtRisk
present
severalGene-expression-basedSignatures
glycosylation
20%IncreasedRiskOfBreastCancerAmongHormonalContraceptionUsers
inverseAssociationBetweenPrediagnosisIntakeAmongWomen
selectiveAccumulationAndInVivo
time-varyingPost-diagnosisAspirinUse
confirmationUsing
rareCaseOfTraumaticBreastNeuroma
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclines
infraredFluorescentImaging
ourExperienceOfHigh-doseRadiotherapy
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
imagingModalities
post-diagnosisLow-doseAspirinUse
limitedEvidenceForAssociation
detectable
betterOutcomeWithNegativePredictiveValue
entity
casesWithNeuromas
soFarHasMainlyAssociatedWithMutationsInBrca1
indicator
pituitaryAdenomas
cancerDevelopment
at25HPost-injectionGreaterInTumorBed
limitedEvidenceForSignificantlyInverseAssociation
fourTypesOfBreastCancer
hasApplied
givenConcernsAboutGadolinium-basedContrastAgentsAreInvestigated
inConclusionNecessaryAsRoutineClinicalBiomarkerInPatients
increasedRisk
presence
givenConcernsAreInvestigated
trendForLessRadicalSurgicalApproachesInBreastCancerDueBetterUnderstandingOfTumourBiology
confirmed
risk
heterogeneousCancer
necessaryForAdoptionAsClinicalBiomarker
testForBreastCancerDetection
evidenceForAssociationAmongWomen
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
related
increasedRiskOfBreastCancerAmongCurrentContraceptionUsers
routineClinicalBiomarkerInPatientsWithBreastCancer
mayUsedForTumourShrinkagePrior
higher
presenceOfDiseaseAtPresentation
agentsUsed
rareClinicalEntityWithOnlyFewCases
therapy
veryRareClinicalEntityWithCasesHavingReported
consultation
haveIntroduced
henceOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
implementedInScreeningAtRisk
mriProtocols
identified
inverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
patient'sOutcome
woundDrainsPlaced
currentlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
inConclusionNecessaryForAdoptionAsRoutineBiomarkerInPatients
significantlyHigherThanInFamilies
rareEntityWithOnlyFewCasesHavingReportedToDate
oneYear
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombination
mainAnalysis
infraredImagingInNegative
wouldCrucialForApplicationOfStrategies
stratified
confirmationOfSignalAccumulation
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
associationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
involved
lowDiagnosticSensitivityForWomen
evidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
associationBetweenPrediagnosisIntake
cancerClusteringInPatients
inConclusionNecessaryForAdoptionAsClinicalBiomarker
dose-dependentReductionInBrca1Levels
time-varyingLow-doseAspirinUse
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesMainlyWithTrastuzumab
chestWallDisease
theirAbilityInTheirOriginallyTargetedPopulationsOfBreastCancer
secondaryConfirmationUsingNearFluorescentImaging
associationAmongWomen
givenRecentConcernsAreInvestigatedForBreastCancerDiagnosis
riskWithUseOfLevonorgestrelSystem-both
riskAmongCurrentContraceptionUsers
riskOfBreastCancerAmongCurrentContraceptionUsers
aggressiveCourseOfHer2Cancer
relapsedHer2
entityWithOnlyFewCasesHavingReportedToDate
recurrentBreastCancer
age
brcanessPhenotypeInBrca1TnbcCells
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedMainlyWithTrastuzumab
increasedRiskAmongCurrentContraceptionUsers
designed
diagnosticImaging
givenRecentConcernsAboutContrastAgentsAreInvestigated
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesWithTrastuzumab
historyOfBreastSurgery
theirAbilityOfPrognosisPredictionInTheirPopulationsOfBreastCancer
involvedInCancerDevelopment
potentialOfAionAsEffectiveContrastAgentForBreastCancerDiagnosis
unresectable
familialCancerClusteringInPatientsWithProlactinoma
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomen
inConclusionStillNecessaryForAdoptionAsBiomarkerInPatients
breastCancerPrognosis
formed
missed
20%RiskOfBreastCancerAmongContraceptionUsers
patientsWithBreastCancerReceivingWithAnthracyclines
infraredFluorescentImagingInTripleNegative
mammographicImages
riskStratification
haveReportedMainlyAfterMastectomy
diagnosisOfBreastCancer
ourExperienceOfRadiotherapy
rareClinicalEntityWithOnlyCases
x-rayMammography
study
mayIndicativeOfBenignLesion
veryRareClinicalEntityWithOnlyCases
required
haveReported
primaryBreastCancer
bindingToBreastCancerCellsInVitro
evidenceForInverseAssociation
inverseAssociationAmongWomen
applied
sensitiveTestForBreastCancerDetection
feasibleInCasesAfterAccurateTissueSampling
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
prognosticSignatures
outcomesOfReceptorPositive
secondaryConfirmationOfSignalAccumulationUsingNearImaging
inConclusionStillNecessaryForAdoptionOfCtnAsBiomarkerInPatients
differentialDiagnosisInPatients
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
nationwideRegistries
fewCases
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
agentsUsedInBreastCancerTreatment
furthermoreDiagnosedWithPaAtAgeThanPatientsWithFamilyHistory
currentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
inConclusionStillNecessaryForAdoptionAsRoutineBiomarkerInPatients
inConclusionStillNecessaryForAdoptionAsClinicalBiomarker
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
selectiveAccumulationOfOsteopontinAnd
patientsWithHistoryOfBreastSurgery
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
soFarHasMainlyAssociatedWithMutations
riskOfBreastCancer
henceImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
hasInconsistent
factor
costOfMriExamination
outcomeWithNegativePredictiveValue
greaterRespectively
necessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
similar
overview
significantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
diagnosisOfCardiotoxicity
inverseAssociationBetweenPrediagnosisIntake
necessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
clinicalEntityWithFewCasesHavingReported
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombination
rareEntity
confirmationOfSignalAccumulationUsingNearImaging
reportedInHigherProportion
henceRoutinelyImplementedInScreeningAtIncreasedRisk
betterOutcomeWithGoodPredictiveValue
decreasesInBcMortalityRates
surveillance
riskWithUseOfLevonorgestrelSystem-bothOfPotentiallyImportantFindings
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesWithTrastuzumab
fiveDosesOfTranstuzumab
severalSignatures
processing
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationWithTrastuzumab
inConclusionNecessaryForAdoptionOfCtnAsBiomarkerInPatients
henceOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
reportedInProportionOfPatients
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAlone
haveValidatedByStudiesInCardiotoxicityDiagnosisWithTrastuzumab
statusBesidesFamilyHistory
brcanessPhenotype
effectsModel
confirmationUsingNearFluorescentImaging
courseOfHer2Cancer
potentialAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
associationBetweenPrediagnosisDietaryIntake
itsMinimalSilverIonReleaseProfiles
8/18Cases
inConclusionStillNecessaryAsRoutineClinicalBiomarkerInPatients
stillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
givenConcernsAboutContrastAgentsAreInvestigatedForBreastCancerDiagnosis
theirExperiences
inConclusionNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
time-varyingPost-diagnosisLow-doseAspirinUse
selectiveAccumulationOfOsteopontinInVitroAndInVivo
wouldCrucialForApplication
evidenceForAssociation
henceCurrentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
limitedEvidenceForAssociationBetweenPrediagnosisIntakeAmongWomen
thusWouldCrucialForApplication
association
diagnosticPerformance
soFarHasAssociatedWithMutations
unresectedLocallyAdvancedBreastCancer
stillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
necessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
rareEntityWithOnlyCasesHavingReportedToDate
limitedEvidenceForAssociationBetweenPrediagnosisIntake
diagnosticPerformanceOfPetImagingInPatientsWithBreastCancer
routinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
reported
evaluated
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
breastCancer
diagnosedWithPaAtEarlierAge
performanceOfCxcr4-directedPetImaging
givenConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
hasAppliedToEarlyIdentification
selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
neoadjuvantTreatment
inConclusionStillNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationMainlyWithTrastuzumab
shaped
differentiallyExpressedInFourTypes
entityWithFewCasesHavingReportedToDate
stillNecessary
thematicAnalysis
mostPatientsInStudy
henceOnlyRoutinelyImplementedInScreeningAtRisk
thanKidney
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDoses
cancerInPatients
inConclusionNecessaryAsClinicalBiomarkerInPatients
stillNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
presenting
implementedInScreeningAtIncreasedRisk
evidenceForInverseAssociationBetweenPrediagnosisDietaryIntake
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAlone
routinelyImplementedInScreeningOfWomenAtIncreasedRisk
greaterInTumorBedThanInKidney
inverseAssociation
mayIndicative
387%
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
diagnosticSensitivityForWomenWithBreasts
post-diagnosisAspirinUse
targetedImmuneCell
expressed
henceCurrentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
confirmation
differentiallyExpressedInFourTypesOfBreastCancer
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
finances
mayUsedForTumourShrinkagePriorToSurgery
course
heterogeneousCancerInFemalePatientsWorldwide
currentlyImplementedInScreeningAtRiskOfBreastCancer
routineBiomarkerInPatients
thusWouldCrucialForApplicationOfPreventiveStrategies
farHasMainlyAssociatedWithMutationsInBrca1
clinicalEntityWithFewCases
veryRareEntity
haveValidatedByClinicalStudies
givenConcernsAboutContrastAgentsAreAlsoInvestigated
cohortOfPatientsWithPituitaryAdenomas
limitedEvidenceForInverseAssociationAmongWomen
stillNecessaryForAdoptionAsRoutineBiomarkerInPatients
necessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
high-resolutionImages
updateOnRiskFactors
ageThanPatientsWithNegativeFamilyHistory
copyright
secondaryConfirmation
riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
additional
entityWithCasesHavingReportedToDate
lowSensitivityForWomenWithDenseBreasts
co-encapsulationOfFluorophore
25HPost-injection
inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
entityWithOnlyCasesHavingReportedToDate
formulationOfManagementPlanForAt-riskWomen
henceImplemented
fourTypes
detectionOfBreastCancer
soFarHasAssociated
necessaryForAdoptionAsRoutineBiomarkerInPatients
betterOutcomeWithGoodNegativeValue
overviewOfAbbreviatedBreastMriProtocols
increasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
associationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
aspirinUse
rareClinicalEntityWithOnlyFewCasesHavingReported
121%
henceCurrentlyImplementedInScreeningOfWomenAtRiskOfBreastCancer
strongFamilyHistory
associationBetweenPost-diagnosisUseOfLow-doseAspirin
toolForTargetedTreatment
used
rareClinicalEntityWithFewCases
combinationsOfInductionInBrca1TripleBreastCancer
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntake
areInvestigated
henceCurrentlyImplementedInScreeningOfWomenAtRisk
diagnosticPerformanceInPatientsWithBreastCancer
theirAbilityInTheirTargetedPopulationsOfBreastCancer
accumulationAndInVivo
secondaryConfirmationUsing
finding
breastTumorInNudeMice
feasibleInProperlySelectedCasesWithNeuromasAfterAccurateTissueSampling
human
veryRareClinicalEntityWithOnlyFewCasesHavingReported
CIs
diagnosisOfResponse
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
riskOfBreastCancerAmongCurrentHormonalContraceptionUsers
suvmaxOf35
population
performanceOfPetImagingInPatients
significantlyInverseAssociationBetweenPrediagnosisIntake
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntake
independentFactor
low-doseAspirinUse
theirAbilityInTheirTargetedPopulations
decreases
primaryBreastCancerPatientsTreatedBetween01012010
increasedRiskWithUseOfLevonorgestrelSystem-bothOfPotentiallyImportantFindings
clinicalBiomarkerInPatientsWithBreastCancer
implementedInScreeningAtRiskOfBreastCancer
errors
potentialOfAionAsMultimodalContrastAgent
diagnosisOfAcuteCoronarySyndromes
thanFamiliesOfPatientsWithPituitaryAdenomas
feasibleInCasesWithNeuromasAfterAccurateTissueSampling
accumulationOfOsteopontinInVitroAndInVivo
amountOfObservedVariationInSeromaProduction
formulationOfEffectiveManagementPlanForWomen
follow-up
signatures
lowSensitivity
concerns
theirAbilityInTheirPopulationsOfBreastCancer
significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
rareCaseOfBreastNeuroma
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
transferable
stillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
imagingInvestigations
evidenceForAssociationBetweenPrediagnosisIntake
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntake
tumorImaging
infraredFluorescentDye
inclusionCriteria
givenConcernsAreAlsoInvestigatedForBreastCancerDiagnosis
mostEffectiveTechniqueused
theirAbilityInTheirPopulations
inconsistentResults
associationBetweenIntake
veryRareCaseOfTraumaticBreastNeuroma
aggressiveCourse
amongThemIdentifiedInStudy
givenRecentConcernsAreAlsoInvestigated
givenRecentConcernsAboutContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesMainlyWithTrastuzumab
issuesOfContrastAgents
onlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
inConclusionNecessaryForAdoptionAsRoutineClinicalBiomarker
onlyRoutinelyImplemented
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
henceCurrentlyImplemented
mustAddressedDuringCancerGeneticCounselingConsultations
geneExpression
reduction
20%IncreasedRiskAmongHormonalContraceptionUsers
axillaryLymphNodeMetastasisOfUnknownPrimary
preclinicalPhase
earlierAgeThanPatientsWithNegativeFamilyHistory
inConclusionNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
positiveFamilyHistoryOfMalignancy
time-varyingAspirinUse
infraredImaging
limitedEvidenceForInverseAssociation
henceCurrentlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
veryRareEntityWithFewCasesHavingReportedToDate
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesWithTrastuzumab
screeningOfWomen
52
bcMortalityRates
secondaryConfirmationUsingNearImaging
feasibleInProperlySelectedCasesWithNeuromasAfterTissueSampling
stillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
soFarHasAssociatedWithMutationsInBrca1
combinationsOfInductionInBrca1Wild-typeNegativeBreastCancer
higherThanInFamilies
brd4RegulationInHomologousDnaRepair
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDoses
lowDiagnosticSensitivityForWomenWithBreasts
caseOfBreastNeuroma
performanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer
inConclusionNecessaryForAdoptionAsBiomarkerInPatients
modified
routinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
preciseToolForTargetedTreatmentOfCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
inConclusionNecessaryAsRoutineBiomarkerInPatientsWithBreastCancer
preciseToolForTargetedTreatmentOfCancerIncludingBc
farHasMainlyAssociated
potentialOfAionAsContrastAgent
riskForMalignancy
PA
clinical
20%RiskOfBreastCancerAmongHormonalContraceptionUsers
breastCancerPatientsSerum
non-ideal
preciseToolForTreatmentOfCancerIncludingBc
only35CasesOfTraumaticBreastNeuromas
asymptomaticNeuromas
furthermoreDiagnosedWithPaAtAgeThanPatients
inConclusionNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombination
stageIiiBreastCaner
inConclusionStillNecessaryAsClinicalBiomarkerInPatients
multipleStudies
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombination
time
inConclusionNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
mostPatients
associationBetweenPost-diagnosisUseOfAspirin
evidenced
breastPain
evidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomen
currentlyImplementedInScreeningAtIncreasedRiskOfBreastCancer
clinicalEntityWithOnlyCases
onlyCases
routinelyImplementedInScreeningOfWomenAtRisk
limitedEvidenceForSignificantlyInverseAssociationAmongWomen
haveValidatedByClinicalStudiesMainlyWithTrastuzumab
henceOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
feasibleInProperlySelectedCasesAfterAccurateTissueSampling
feasible
increasedRiskAmongCurrentHormonalContraceptionUsers
preciseToolForTreatmentOfCancer
properlySelectedCases
rareClinicalEntityWithOnlyCasesHavingReported
inConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarker
value
pegylatedMicelles
betInhibitorsAlreadyAvailable
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
inverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
presentingWithRefractoryNeuropathicBreastPain
thusWouldCrucialForApplicationOfStrategies
clinicians
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
model
currentlyRoutinelyImplemented
brd4RegulationInDnaRepair
urgentlyNeeded
sixGlycosylationSites
howeverNon-ideal
infraredFluorescent
necessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
howeverLower
betInhibitorsAvailable
patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
prognosticFactor
woundDrainsPlacedInBreast
massSpectrometry
diagnosis
update
farHasAssociated
henceImplementedInScreeningOfWomenAtRiskOfBreastCancer
cohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
detection
potentialAsEffectiveContrastAgentForBreastCancerDiagnosis
prolactinoma
stillNecessaryForAdoptionOfCtnAsClinicalBiomarker
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesMainlyWithTrastuzumab
mayUsedForTumourShrinkage
evidenceForInverseAssociationBetweenPrediagnosisIntake
secondaryConfirmationOfSignalAccumulation
limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
currentlyRoutinelyImplementedInScreeningOfWomenAtRisk
performanceInPatients
evidenceForInverseAssociationAmongWomen
largeCohortOfPatientsWithAdenomasInOutpatientClinic
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclines
neoadjuvantAnti-her2Treatment
significantlyInverseAssociationAmongWomen
sensitivity
howeverSignificantlyLower
strong
20%IncreasedRiskOfBreastCancerAmongContraceptionUsers
inConclusionNecessaryAsBiomarkerInPatientsWithBreastCancer
inConclusionNecessaryAsRoutineBiomarker
commonAgents
rareClinicalEntityWithCases
henceCurrentlyRoutinelyImplementedInScreeningAtIncreasedRisk
selectiveAccumulationOfFluorescentOsteopontinAnd
routinelyImplemented
formulationOfManagementPlan
significantlyLower
combinationsOfInductionInBrca1BreastCancer
currentlyImplementedInScreeningAtRisk
populationOfTnbcPatients
necessaryForAdoptionAsRoutineClinicalBiomarker
inConclusionStillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
amountOfVariationInSeromaProduction
givenRecentConcernsAboutGadolinium-basedContrastAgentsAreInvestigatedForBreastCancerDiagnosis
sensitivityForWomenWithDenseBreasts
selectiveAccumulationInVitroAnd
at25HPost-injectionGreaterInTumorBedThanInKidney
co-encapsulation
farHasMainlyAssociatedWithMutations
neuroma
at25HPost-injectionGreaterThanInKidneyRespectively
infraredFluorescentImagingInNegative
henceCurrentlyImplementedInScreeningOfWomenAtIncreasedRisk
secondaryConfirmationOfSignalAccumulationUsingNearFluorescentImaging
theirAbilityOfPrognosisPredictionInTheirTargetedPopulations
areUsed
unusual
theirAbilityOfPrognosisPredictionInTheirPopulations
managementOfRecurrentHer2
anti-her2Therapy
formedByCo-encapsulationInPegylatedMicelles
farHasAssociatedWithMutationsInBrca1
novelStrategies
registries
outcomeWithValue
diagnosticSensitivityForWomen
veryRareClinicalEntityWithFewCasesHavingReported
23Cross-sectionalStudies
existingContrastAgents
henceRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationWithTrastuzumab
potentialAsContrastAgent
cohort
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithTrastuzumab
stillNecessaryForAdoptionAsRoutineClinicalBiomarker
conclusion
familialCancerClustering
rareEntityWithCasesHavingReportedToDate
68Ga-Pentixafor
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationWithTrastuzumab
significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesMainlyWithTrastuzumab
necessity
subcutaneousBreastTumor
evidencedByIncreaseInContrast
20%RiskAmongHormonalContraceptionUsers
expressedInFourTypesOfBreastCancer
furthermoreDiagnosedWithPaAtEarlierAgeThanPatients
ageOf25Years
diagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
femalePatientsWorldwide
necessaryForAdoptionOfCtnAsBiomarkerInPatients
theirAbilityInTheirOriginallyTargetedPopulations
onlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
relativesOfPatientsWithPa
patient
evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
20%RiskAmongContraceptionUsers
caseOfTraumaticBreastNeuroma
toolForTargetedTreatmentIncludingBc
strategies
haveReportedAfterMastectomy
significantlyHigherThanInFamiliesOfNfpaPatients
inConclusionNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
only35CasesOfBreastNeuromas
familyHistoryOfCancer
feasibleInCasesWithNeuromasAfterTissueSampling
elderlyPatientWithHer2
significantlyHigher
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
inTermHasFound
osteopontinPeptide
brd4RegulationInHomologousRecombination-mediatedDnaRepair
outcomesOfPositive
negativeFamilyHistory
veryRareEntityWithOnlyCasesHavingReportedToDate
evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
veryRareEntityWithCasesHavingReportedToDate
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
diagnosticPerformanceOfPetImaging
limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
thereforeHasAppliedToEarlyIdentification
henceCurrentlyOnlyRoutinelyImplementedInScreeningAtRisk
selectedCasesWithAsymptomaticNeuromas
cases
currentlyImplementedInScreeningAtIncreasedRisk
use
accumulationOfFluorescentOsteopontinAnd
selectiveAccumulation
patientsWithBreastCancer
moreRecentlyHaveDeveloped
increasedRiskOfBreastCancer
january312018
formedByCo-encapsulationOfFluorophoreInPegylatedMicelles
stillNecessaryForAdoptionAsBiomarkerInPatients
contrastAfterInjection
compared
imagingInNegativeInVitro
secondaryConfirmationOfSignalAccumulationUsing
commonCancer
available
routineClinicalBiomarker
non-functioningPituitaryAdenomas
decades
largeCohortOfPatients
inConclusionStillNecessaryForAdoptionOfCtnAsClinicalBiomarker
accumulationInVitroAnd
betterOutcomeWithValue
earlierAge
mostCommonAgentsUsedInBreastCancerTreatment
firstDiagnosisOfBreastCancer
clinicalEntityWithCasesHavingReported
95%ConfidenceIntervals
patientsWithProlactinoma
furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithFamilyHistory
particular
exposureLag
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
limitedEvidenceForAssociationAmongWomen
brd4RegulationInRecombination-mediatedDnaRepair
currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
accumulationOfFluorescentOsteopontinInVitroAndInVivo
recentlyIntroducedPetProbe68ga-pentixafor
injury
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntake
currentlyOnlyRoutinelyImplemented
inConclusionStillNecessaryAsBiomarkerInPatientsWithBreastCancer
newValue-basedHealthcareParadigm
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombination
toolForTreatment
itsWidespreadUse
introducedPetProbe68ga-pentixafor
onlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
higherThanInFamiliesOfNfpaPatients
furthermoreDiagnosed
currentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
inLongTermHasFound
areAlsoInvestigatedForBreastCancerDiagnosis
oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
significantlyInverseAssociationBetweenPrediagnosisDietaryIntake
meanSuvmax
moreDirectional
largeCohortOfPatientsWithAdenomas
managementOfHer2
heterogeneousCancerInPatientsWorldwide
clinicalEntityWithOnlyFewCases
henceRoutinelyImplementedInScreeningAtRiskOfBreastCancer
7/18Patients
BRCA1
rareClinicalEntityWithFewCasesHavingReported
expressedInFourTypes
inConclusionNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
clinicalBiomarker
haveValidatedByClinicalStudiesWithTrastuzumab
mutationalStatusBesidesFamilyHistory
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
20%IncreasedRiskAmongContraceptionUsers
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneWithTrastuzumab
limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntake
henceImplementedInScreeningOfWomenAtIncreasedRisk
diagnosisOfCoronarySyndromes
isIn
evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
toolForTreatmentIncludingBc
inConclusionStillNecessaryAsRoutineBiomarker
historyOfTranstuzumab-inducedCardiacDysfunction
latestTreatmentOptions
riskWithUseOfLevonorgestrelIntrauterineSystem-both
outpatientClinic
evidenceForAssociationBetweenPrediagnosisDietaryIntake
inConclusionStillNecessaryAsBiomarker
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatients
confirmationOfSignalAccumulationUsing
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsMainlyWithTrastuzumab
inConclusionNecessaryAsBiomarker
patientsWithPrimaryBreastCancer
veryRareCaseOfBreastNeuroma
clinicalEntityWithCases
traumaticNeuroma
accumulation
limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntake
infraredImagingInTripleNegative
lapatinibCombined
generallyReserved
smallPatientCohort
riskAmongCurrentHormonalContraceptionUsers
evidenceForSignificantlyInverseAssociationAmongWomen
necessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
oneYearOfDiseaseControl
henceCurrentlyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
evidenceForSignificantlyInverseAssociation
contrastWithImagingModalities
platinumSalts
veryRareEntityWithOnlyFewCasesHavingReportedToDate
developedCbcDuring
outcomeWithGoodNegativeValue
binding
haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationMainlyWithTrastuzumab
presentingWithRefractoryBreastPain
henceRoutinelyImplementedInScreeningAtRisk
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombination
implementedInScreeningAtIncreasedRiskOfBreastCancer
veryRareClinicalEntityWithOnlyFewCases
benign
increaseInContrast
diagnosisInPatientsWithHistoryOfBreastSurgery
soFarHasMainlyAssociated
significantlyInverseAssociation
clinicalEntityWithOnlyFewCasesHavingReported
accumulationOfOsteopontinAnd
only35Cases
lower
clinicalEntityWithOnlyCasesHavingReported
henceCurrentlyRoutinelyImplementedInScreeningAtRisk
25MonthsFromDiagnosis